Bristol-Myers Squibb and 3 Top Pharma Stocks with Earnings Investors Must See
Amgen Inc. (NASDAQ:AMGN) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Net income decreased -15.63% to $788 million ($1.4 per diluted share) in the quarter versus a net gain of $934 million in the year-earlier quarter. Revenue rose 11.25% to $4.42 billion from the year-earlier quarter.
Amgen Inc. reported adjusted net income of $1.4 per share. By that measure, the company beat the mean analyst estimate of $1.39. It beat the average revenue estimate of $4.37 billion.